MIVI Neuroscience
Latest round
- Series B
Last raised
- Jan 2021
Total raised
- $35M
Investors
- 4
About MIVI Neuroscience
MIVI Neuroscience, Inc.Founded in 2013 and headquartered in Eden Prairie, US, MIVI Neuroscience, Inc. operates with a focus on stroke intervention technologies.MIVI Neuroscience specializes in innovative solutions for stroke treatment, primarily focusing on their flagship product, the DAISe™ Thrombectomy System. This advanced mechanical device is engineered to assist neurointerventional specialists in clot retrieval during stroke interventions, thereby minimizing distal embolization. The DAISe™ system addresses longstanding challenges in stroke management by enhancing the efficacy of clot removal procedures, ultimately aiming to improve patient outcomes in critical scenarios. MIVI collaborates closely with healthcare providers, specifically neurointerventional specialists, to tailor their offerings to the pressing needs of the medical community.MIVI Neuroscience operates on a business model that focuses on direct sales to healthcare institutions and neurointerventional specialists, fostering relationships that enhance product adoption in clinical settings. The revenue structure is centered around the provision of their DAISe™ Thrombectomy System, which is positioned as a crucial tool in the treatment of ischemic strokes. Transactions typically involve direct sales agreements with hospitals and medical centers, where MIVI supplies the thrombectomy systems and possibly associated training and support services. Pricing plans for their products reflect the specialized nature of their offerings, catering to the unique needs of healthcare providers who require state-of-the-art technology for advanced stroke interventions.In January 2021, MIVI Neuroscience, Inc. The company is exploring opportunities to expand its market presence beyond the United States, targeting regions with increasing demand for advanced stroke treatment technologies.
Who invested in MIVI Neuroscience
4 investors across 1 round
See all investors in MIVI Neuroscience
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 21, 2021
Amount
$35M
Investors
Questions about MIVI Neuroscience
Who invested in MIVI Neuroscience?
MIVI Neuroscience has 4 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has MIVI Neuroscience raised?
MIVI Neuroscience has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did MIVI Neuroscience last raise money?
MIVI Neuroscience's most recent round on record is a Series B, in Jan 2021.
What does MIVI Neuroscience do?
MIVI Neuroscience is a healthcare company.
Where is MIVI Neuroscience headquartered?
MIVI Neuroscience is headquartered in Eden Prairie, US.
Which VCs invest in companies like MIVI Neuroscience?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Kleiner Perkins and Lightspeed Venture Partners back healthcare companies at MIVI Neuroscience's stage. Their profiles are linked below.
VCs backing healthcare startups at Series B
Raising like MIVI Neuroscience? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.